综述

抗肿瘤单克隆抗体药物研究进展

  • 孙燕 孟胜利
展开
  • 430074 中南民族大学生命科学学院(孙燕);430207 武汉生物制品研究所有限责任公司病毒性疫苗研究一室(孟胜利)

网络出版日期: 2025-08-16

Advances in research on monoclonal antibodies against tumors

Expand
  • *College of Life Scineces, South-Central University for Nationalities, Wuhan 430074, China

Online published: 2025-08-16

摘要

 抗肿瘤细胞表面抗原的单克隆抗体(单抗)可以有效治疗肿瘤。这些单抗药物可通过直接作用于肿瘤细胞、改变机体免疫应答、运送药物和重新激发机体免疫等机制来抗击肿瘤。此文就单抗治疗肿瘤的作用靶点、机制、代表性药物和新策略进行综述。

本文引用格式

孙燕 孟胜利 . 抗肿瘤单克隆抗体药物研究进展[J]. 国际生物制品学杂志, 2016 , 39(3) : 128 -133 . DOI: 10.3760/cma.j.issn.1673-4211.2016.03.005

Abstract

 By targeting surface antigens expressed on tumor cells, monoclonal antibodies have demonstrated efficacy as cancer therapeutics. Monoclonal antibody drugs can directly act on tumor cells, change body's immune response, deliver drugs and awaken body's immune system to fight cancer. This paper summarizes the therapeutic target, mechanism, representative drugs and new strategies of monoclonal antibodies in cancer therapy.
文章导航

/